Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, Sami Corwin from William Blair maintained a Buy rating on Beam Therapeutics.
CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported financial ...
Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could differentiate ...
GREEN BAY, Wis. (WBAY) - Across our community, you’ll find unsung heroes giving of their time, talent and treasures to make Northeast Wisconsin a great place to live. WBAY is excited to begin a new ...
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
ConnectiCare has made a donation of “more than 80 boxes of pads, tampons, and other period supplies to The Diaper Bank of Connecticut’s (CT) Beam program,” according to a statement. “Everyone deserves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results